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Background
Interest in the relation between personality and depression is not new. Ancient classifications focused on temperament with depression largely considered an epiphenomenon. Melancholic temperament was associated with individuals who were moody, pessimistic, and vulnerable to episodic depression. A neurobiological explanation was even offered: an excess of black bile. The idea that personality is intimately tied up with psychopathology has persisted. Kraepelin postulated that a cyclothymic disposition inclined patients to manic-depressive insanity, while Kretschmer considered that cycloids were a forme fruste of manic-depressive psychosis. Psychoanalysts believed that patients with depression had undue interpersonal dependency, obsessionality, and labile self-esteem. 3 More recent attempts to classify depression have frequently incorporated personality variables and often attempted to link them to treatment response. Eysenck claimed that psychotic and neurotic depression were related to the underlying personality dimensions of psychoticism and neuroticism. 4 Paykel produced a depressive typology with 4 categories: anxious depressives, hostile depressives, young depressives with personality disorder, and psychotic depressives. He reported that the subtypes had a differential response to amitriptlyline. 5 Winokur et al 6 introduced the concept of depressive spectrum disease defined by the presence of alcoholism or antisocial personality disorder in first-degree relatives. Such patients were deemed less amenable to traditional treatments for depression. Akiskal's typology is outlined by Bagby et al, 2 but again links personality, depression, and treatment response.
Personality Disorders and Personality Traits
In 1980, the separation of personality disorder and depression in DSM-III largely stopped the incorporation of personality variables in the classification of depression. Personality pathology was now seen as a comorbid disorder with its own axis. The view appeared to be that simply diagnosing each disorder was the best conceptualization. This separation, while stimulating research, has also led to stagnation and apparent endless speculation on how common personality disorders are in depressed patients (generally conceded to be very common) and what types of personality disorder are most frequent (this varies depending on the sample studied). In my view, personality disorder categories are so flawed and overlapping that the argument is barely worth pursuing. Similarly, studying the neurobiology and genetics of such flawed phenotypes are unlikely to yield useful results.
Interest has therefore increasingly turned to personality traits associated with depression, particularly neuroticism or harm avoidance and negative emotionality. Here the evidence is more consistent. Bagby et al 2 conclude that empirical work consistently demonstrates that depressed individuals exhibit elevated scores on neuroticism and have higher negative emotionality. They also note that reduced levels of extroversion and conscientiousness are reported, although this is less consistent in my view. Dr Foster and Dr MacQueen 1 present the evidence linking high neuroticism scores to the biological differences that have also been reported in depression. These include greater hypothalamic-pituitary-adrenal activation, reduced brain-derived neurotrophic factor, and less convincingly, links to the serotonin transporter 5-HTTLPR polymorphisms. They caution that we are currently unable to link personality traits to illnesses such as depression via reliable, shared biological markers. However, as they go on to say, the fact that we even consider that determining biological factors underlying depression and personality is a valid question is progress.
Personality and Treatment Outcome in Depression
For many clinicians the principle reason for their interest in the relation between personality and depression can be reduced to 2 fundamental questions. The first is whether a depressed patient with personality pathology has a different outcome from a depressed patient with no pathology. The second is whether a different treatment should be offered to patients with depression and personality pathology, compared with those who are depressed without personality pathology.
The first question is not as straightforward as was initially believed. There is reasonably consistent evidence that high neuroticism or harm avoidance scores are associated with poorer outcome, in initial response and longer-term outcome. 7 The presence of comorbid personality disorders in depressed patients was also generally believed to predict a worse outcome. This belief was challenged by a review, 8 which was followed by 2 metaanalyses that contradicted each other. 9,10 A further metaanalysis is planned; however, it seems reasonable to say that the current consensus is that the presence of comorbid personality disorder in depressed patients has a slight negative effect. Newton-Howes et al 10 calculated that a sample of over 1000 would be necessary to detect this effect, underlining how weak the impact of personality disorder on outcome is. As Bagby et al 2 put it, a more optimistic view of outcome is now justified. The implication is that clinicians should not consider a diagnosis of personality disorder to necessarily be an indicator of poor prognosis in patients with depression.
The other important question is whether we should modify treatment for depression in patients who also have a personality disorder. Traditionally, it has seemed sensible to favour some type of psychotherapy to address interpersonal issues as well as mood. Somewhat counterintuitively, the modest available evidence suggests the opposite, that is, that the negative effect of personality disorder may be attenuated by drug treatment. Bagby et al 2 note that high neuroticism scores may be a negative diagnostic indicator for psychotherapy, but not pharmacotherapy, and suggest that individuals with elevated neuroticism may be too emotionally dysregulated to recruit the psychological resources required to engage in psychotherapeutic efforts. One metaanalysis 10 noted a trend for comorbid personality disorder to worsen the prognosis of patients given psychotherapy and drugs, more than those given drugs alone or electroconvulsive therapy. We have reported that comorbid personality disorder had no overall effect on the short-term outcome of depression in patients treated with drugs; 11 however, it does adversely affect outcome in patients given psychotherapy. 12 Therefore, the limited evidence at present suggests favouring drug treatment over psychotherapy in depressed patients with comorbid personality pathology.
Whether we should choose specific drugs for depressed patients with comorbid personality disorder is a further relevant question. The evidence, so far, implies that it might be wise to avoid tricyclic antidepressants in patients with comorbid cluster B personality disorders, 11 but otherwise there is little to guide treatment. In summary, despite insufficient evidence, it is at least worth considering modifying our treatments for depressed patients with comorbid personality disorders.
Conclusions
These 2 reviews summarize the current state of the relation between personality and depression. The current state of the art is clearly rudimentary. We need to refine the way we conceptualize the relation between personality and depression (and all other Axis I disorders for that matter) beyond the simplistic Axis I and Axis II dissection in DSM-IV. Refining the behaviours we select and incorporating personality back to descriptions of depression might be a start. Some type of negative affectivity, be it neuroticism or harm avoidance or negative emotionality, is common in humans and intimately tied to mood and anxiety. Attempting to study the genetics and neurobiology of these negative affectivity traits may give us clues as to how to more accurately classify the heterogeneous mass of patients we diagnose as having mood and anxiety disorders. The desired outcome, of course, is to refine how we can better treat depression and personality pathology and seek a better outcome for our patients.
